Economy May Push Med-Tech Innovation From Start-Ups To Larger Firms
This article was originally published in The Gray Sheet
Executive Summary
Larger, established device firms could seize the role typically played by start-ups in early product development, given the growing difficulties in commercializing new technology and gaining access to capital, say venture capitalists and industry execs
You may also be interested in...
Venture Capital Resilient For MedTech Even As Public Markets Wilt – Report
The U.S. medical technology industry's access to private venture capital remained largely intact in the first half of 2008, despite a global credit crunch that has depressed public equity financing in the sector, according to a 1report by consulting firm Ernst & Young
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.